Optimized nanoadjuvants enhance in situ tumor vaccine for ovarian cancer

This new article publication from Acta Pharmaceutica Sinica B, discusses how molecular glue triggers degradation of PHGDH by enhancing the interaction between DDB1 and PHGDH.

AbbVie seeks Restasis follow-up with small option fee for Aldeyra’s eye drops, despite a potential ‘imminent’ CRL

As AbbVie’s sales of its dry eye disease drug Restasis continue to slide following the first generic approval in February 2022, the Big Pharma is

November 2, 2023

Socioeconomic conditions can shape the brain’s sensitivity to rewarding experiences

MIT neuroscientists have found that the brain’s sensitivity to rewarding experiences -; a critical factor in motivation and attention -; can be shaped by socioeconomic

January 22, 2024

Three Ways to Protect Infants From RSV This Winter

In this video interview, Paul Offit, MD, of Children’s Hospital of Philadelphia, discusses three preventive measures to protect infants from respiratory syncytial virus (RSV) this

November 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.